Profile data is unavailable for this security.
About the company
China Medical System Holdings Ltd is an investment holding company principally engaged in the production of medicines, as well as marketing, promotion and sales of drugs. The Company's products include Plendil, Ursofalk, Augentropfen Stulln Mono Eye Drops, Hirudoid, Atopic Piel Series and Vmonalisa, among others. Its major marketed products cover the cardio-cerebrovascular, gastroenterology, ophthalmology, dermatology and medical aesthetic fields. The Company distributes its products within domestic market and to overseas markets.
- Revenue in HKD (TTM)7.70bn
- Net income in HKD1.53bn
- Incorporated2006
- Employees5.78k
- LocationChina Medical System Holdings LtdUnit 2106, 21/F, Island Place Tower, 510, North Point Hong KongHKG
- Phone+86 75 582416868
- Fax+86 75 582416622
- Websitehttps://web.cms.net.cn/zh/home/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Luye Pharma Group Ltd | 6.93bn | 845.64m | 12.30bn | 5.23k | 14.55 | 0.8608 | 7.23 | 1.78 | 0.2248 | 0.2248 | 1.84 | 3.80 | 0.236 | 2.44 | 3.02 | 1,314,909.00 | 3.11 | 2.80 | 5.47 | 4.45 | 68.73 | 70.53 | 13.18 | 10.39 | 1.20 | 3.14 | 0.4103 | 11.82 | 2.70 | 3.50 | -11.94 | -16.39 | -14.05 | -- |
Shanghai Henlius Biotech Inc | 6.19bn | 759.89m | 12.36bn | 3.55k | 16.31 | 4.37 | 10.61 | 2.00 | 1.39 | 1.39 | 11.34 | 5.21 | 0.5764 | 1.90 | 6.82 | 1,702,200.00 | 7.07 | -8.59 | 14.25 | -14.14 | 73.23 | 71.77 | 12.27 | -27.37 | 0.329 | 7.60 | 0.6113 | -- | 67.82 | 273.51 | 178.53 | -- | 49.14 | -- |
SSY Group Ltd | 6.47bn | 1.37bn | 12.42bn | 5.80k | 9.14 | 1.72 | 6.79 | 1.92 | 0.4593 | 0.4593 | 2.18 | 2.44 | 0.5418 | 2.75 | 3.07 | 1,155,141.00 | 11.54 | 10.51 | 14.88 | 14.03 | 54.39 | 58.72 | 21.30 | 18.62 | 2.06 | 28.65 | 0.323 | 38.56 | 0.4505 | 9.10 | 17.44 | 7.66 | 3.94 | 13.56 |
3SBio Inc | 9.24bn | 1.82bn | 16.31bn | 5.61k | 9.11 | 1.03 | 7.22 | 1.76 | 0.7473 | 0.7473 | 3.79 | 6.59 | 0.3575 | 1.52 | 6.87 | 1,708,233.00 | 7.25 | 7.44 | 10.26 | 9.29 | 85.94 | 82.91 | 20.27 | 21.50 | 1.57 | 141.55 | 0.1998 | -- | 13.84 | 11.26 | -19.13 | 3.94 | 8.78 | -- |
Simcere Pharmaceutical Group Ltd | 6.96bn | -1.21bn | 16.68bn | 6.41k | -- | 2.21 | -- | 2.40 | -0.4626 | -0.4626 | 2.70 | 2.98 | 0.5198 | 2.19 | 2.64 | 990,578.20 | -9.04 | 10.17 | -11.71 | 15.60 | 77.02 | 78.82 | -17.40 | 17.50 | 1.88 | 0.4721 | 0.1461 | 46.68 | 4.49 | 7.92 | -23.22 | -0.5213 | 23.93 | -- |
Grand Pharmaceutical Group Ltd | 10.59bn | 2.41bn | 17.82bn | 10.78k | 7.29 | 1.13 | 6.20 | 1.68 | 0.6885 | 0.6885 | 3.03 | 4.43 | 0.4472 | 3.62 | 4.54 | 1,005,064.00 | 10.25 | 10.09 | 14.21 | 14.01 | 59.00 | 61.97 | 22.92 | 22.35 | 1.09 | -- | 0.2232 | 26.94 | 10.12 | 12.06 | -9.59 | 21.41 | 5.69 | 24.77 |
Zai Lab Ltd | 2.51bn | -2.32bn | 18.99bn | 2.18k | -- | 3.42 | -- | 7.57 | -2.39 | -2.39 | 2.58 | 5.58 | 0.3083 | 3.04 | 5.52 | -- | -28.50 | -37.72 | -34.92 | -42.72 | 63.17 | 64.75 | -92.44 | -282.44 | 3.29 | -- | 0.0908 | -- | 24.03 | 360.03 | 24.51 | -- | -3.45 | -- |
The United Laboratories Intl. Hldgs Ltd. | 15.38bn | 3.19bn | 19.91bn | 15.00k | 6.24 | 1.34 | 5.22 | 1.30 | 1.76 | 1.76 | 8.46 | 8.17 | 0.6578 | 3.30 | 5.67 | 1,025,069.00 | 13.65 | 7.89 | 20.72 | 12.64 | 46.15 | 44.17 | 20.75 | 12.73 | 1.72 | -- | 0.1532 | 28.99 | 21.22 | 12.84 | 70.85 | 31.66 | 24.19 | 46.04 |
China Traditional Chinese Med Hldg CoLtd | 18.88bn | 1.01bn | 22.11bn | 17.72k | 21.95 | 0.9425 | 9.63 | 1.17 | 0.20 | 0.20 | 3.75 | 4.66 | 0.453 | 1.54 | 1.82 | 1,091,315.00 | 2.62 | 4.60 | 4.01 | 7.07 | 49.86 | 57.07 | 5.77 | 9.77 | 1.51 | 7.39 | 0.1808 | 17.35 | 26.69 | 9.99 | 68.11 | -2.24 | -12.75 | -- |
China Medical System Holdings Ltd | 7.70bn | 1.53bn | 22.20bn | 5.78k | 14.57 | 1.26 | 12.55 | 2.88 | 0.6246 | 0.6246 | 3.15 | 7.23 | 0.384 | 2.89 | 5.65 | 1,350,396.00 | 7.51 | 18.44 | 8.53 | 21.14 | 74.13 | 75.47 | 19.56 | 34.26 | 3.97 | -- | 0.0667 | 40.14 | -12.43 | 8.08 | -26.33 | 5.35 | 38.69 | 5.19 |
HUTCHMED (China) Ltd | 4.75bn | -326.14m | 27.32bn | 1.97k | -- | 4.75 | -- | 5.76 | -0.3881 | -0.3881 | 5.50 | 6.60 | 0.4775 | 7.10 | 4.15 | 2,387,551.00 | -3.30 | -14.35 | -4.65 | -20.43 | 41.67 | 36.57 | -6.91 | -31.44 | 2.68 | -- | 0.0984 | -- | 96.52 | 31.38 | 127.93 | -- | 38.65 | -- |
WuXi XDC Cayman Inc | 3.07bn | 652.56m | 28.49bn | 1.50k | 44.30 | 4.33 | 38.33 | 9.28 | 0.5361 | 0.5361 | 2.71 | 5.49 | 0.5586 | 21.31 | 2.85 | 2,604,699.00 | 11.88 | -- | 15.43 | -- | 30.96 | -- | 21.27 | -- | 4.02 | -- | 0.0113 | -- | 114.44 | -- | 82.07 | -- | -- | -- |
Data as of Oct 10 2024. Currency figures normalised to China Medical System Holdings Ltd's reporting currency: Hong Kong Dollar HKD
Holder | Shares | % Held |
---|---|---|
The Vanguard Group, Inc.as of 04 Jul 2024 | 47.17m | 1.93% |
Lazard Asset Management LLCas of 30 Jun 2024 | 30.24m | 1.24% |
Dimensional Fund Advisors LPas of 04 Jul 2024 | 30.11m | 1.23% |
Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 21.63m | 0.89% |
Fidelity Management & Research Co. LLCas of 30 Jun 2024 | 18.78m | 0.77% |
GF Fund Management Co., Ltd.as of 31 Dec 2023 | 17.38m | 0.71% |
BlackRock Fund Advisorsas of 04 Jul 2024 | 15.46m | 0.63% |
Norges Bank Investment Managementas of 31 Dec 2023 | 14.74m | 0.60% |
Bankinter Gesti�n de Activos SA SGIICas of 31 Dec 2023 | 9.23m | 0.38% |
Handelsbanken Fonder ABas of 31 Jul 2024 | 8.11m | 0.33% |
More ▼
Data from 31 Dec 2023 - 06 Aug 2024Source: FactSet Research Systems Inc.